Related Experiment Video
Updated: Feb 28, 2026
Generation of Recombinant Arenavirus for Vaccine Development in FDA-Approved Vero Cells
Published on: August 1, 2013
Recently Patented Viral Nucleotide Sequences and Generation of Virus-Derived Vaccines
Srividhya Venkataraman1, Tauqeer Ahmad2, Mounir A Haidar2
1Department of Cell and Systems Biology, University of Toronto, Toronto, Ontario M5S 3B2, Canada.
Background:
With an increase in comprehension of the molecular biology of viruses, there has been a recent surge in the application of virus sequences and viral gene expression strategies towards the diagnosis and treatment of diseases.
Results:
The scope of the patenting landscape has widened as a result and the current review discusses patents pertaining to live / attenuated viral vaccines. The vaccines addressed here have been developed by both conventional means as well as by the state-of-the-art genetic engineering techniques.
Conclusion:
This review also addresses the applications of these patents for clinical and biotechnological purposes.
